Miami Breast Cancer Conference 2025
The 42nd annual Miami Breast Cancer Conference was held from March 6-9, 2025. Visit the links below to explore some of the topics covered at this meeting for...
Read MoreHow to Prepare for Your Visit With Your Healthcare Team
Whether your MBC diagnosis is new, or you’ve been living with the disease for some time, communicating with your healthcare team is important so you can receive...
Read MoreSide Effects of MBC Treatments: Pain and Neuropathy
MBC treatment aims to extend life but also comes with side effects that can impact quality of life. There are ways to manage the different types of side effects...
Read MoreUpcoming MBC Conferences in March
There are several conferences this month for people living with MBC. Some can be attended virtually. Conferences geared toward patients may offer time for...
Read MoreWhat Are Radiopharmaceuticals and How Are They Used in MBC?
A drug attached to a radioactive molecule is called a radiopharmaceutical, also known as a radioactive drug. The drug attached to the radioactive molecule guides...
Read MoreFDA Approves Enhertu® for Hormone Receptor-Positive, HER2-Low or HER2-Ultralow MBC
In December 2019, the US Food and Drug Administration (FDA) originally approved trastuzumab deruxtecan (Enhertu®), an antibody drug conjugate (ADC), for people...
Read MoreDissecting Trial Information on ClinicalTrials.gov
ClinicalTrials.gov is the website where clinical trials are recorded and where you can find important information about each trial. The details we provide about...
Read MoreFDA Approves Datroway®
On January 17, 2025, the FDA approved datopotamab deruxtecan-dlnk (Datroway®, Daiichi Sankyo, Inc.) for the treatment of people with hormone receptor-positive...
Read MoreSide Effects of MBC Treatments: Fatigue
MBC treatment aims to extend life but also comes with side effects that can impact quality of life. There are ways to manage the different types of side effects...
Read MoreSEARCH OUR SITE
for past articles or specific information.